Anjali Srivastava

RIPK3-MLKL signaling activates mitochondrial CaMKII and drives intrarenal extracellular matrix production during CKD.

S. Rath, O. Kulkarni, S. R. Mulay, 2022, Matrix biology : journal of the International Society for Matrix Biology.

6,7-Dihydroxycoumarin ameliorates crystal-induced necroptosis during crystalline nephropathies by inhibiting MLKL phosphorylation.

A. Gaikwad, S. R. Mulay, Yogesh B. Narkhede, 2021, Life sciences.

Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2

Rajeev K Sukumaran, D. Ghosh, Dhruv Batra, 2021, medRxiv.

Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease.

S. Rath, Anjali Srivastava, Bhawna Tomar, 2023, Life sciences.

Involvement of Inflammasome Components in Kidney Disease

J. Pedraza-Chaverri, S. R. Mulay, A. Scholze, 2022, Antioxidants.

Advanced non-invasive diagnostic techniques for visualization and estimation of kidney fibrosis.

S. R. Mulay, A. Gaikwad, Anjali Srivastava, 2021, Drug discovery today.

'PARP'ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors.

Y. Kulkarni, S. R. Mulay, A. Gaikwad, 2020, Drug discovery today.